# Public Health Institute Names Ken Shapiro Chief Development and Strategic Initiatives Officer > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/adolescent-cannabis-use-mental-health-phi-leadership/ > **Published:** 2026-04-06T21:55:22-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:28:52-04:00 > **Clinical Summary:** Explore adolescent cannabis use mental health focus with PHI's new Chief Development Officer Ken Shapiro advancing research and policy initiatives. --- ✦ New CED Clinical Relevance #45 Clinical Context Background information relevant to the evolving [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) landscape. ResearchPediatricsMental HealthPolicySafety Clinical Summary The Public Health Institute’s appointment of Ken Shapiro as Chief Development and Strategic Initiatives Officer reflects the organization’s commitment to advancing research and policy initiatives around cannabis use, particularly among vulnerable populations such as adolescents. Recent research disseminated through media outlets like NPR highlights concerning trends in teen cannabis use, underscoring the need for evidence-based public health approaches and clinical guidance. This leadership transition suggests PHI will continue to prioritize rigorous epidemiological research and strategy development to inform clinical practice and policy recommendations regarding adolescent cannabis exposure. For clinicians, this institutional focus means access to emerging population-level data on cannabis use patterns and harms that can inform screening, counseling, and prevention conversations in primary care and pediatric settings. Understanding the scope and trajectory of [adolescent cannabis use](https://cedclinic.com/adolescent-cannabis-use-and-anxiety-research/) is critical for identifying at-risk patients and providing developmentally appropriate clinical interventions. Clinicians should stay informed of PHI’s forthcoming research findings to better counsel young patients and families about the evolving evidence on [cannabis safety](https://cedclinic.com/respiratory-effects-inhalational-marijuana/) and neurodevelopmental effects. Dr. Caplan’s Take “What we’re seeing in the research is that adolescent cannabis use correlates with measurable changes in brain development, particularly in areas governing impulse control and decision-making, and this isn’t something I can ethically ignore in my clinical conversations with families regardless of changing legal status.” Clinical Perspective While leadership appointments at public health organizations reflect the growing institutional focus on cannabis-related research and policy, clinicians should note that administrative changes alone do not directly inform clinical decision-making at the point of care. The referenced research on adolescent cannabis use appears relevant to clinical practice, particularly given evidence that early cannabis exposure may affect neurodevelopment and mental health outcomes in vulnerable populations. However, without access to the specific study methodology, effect sizes, and potential confounders (such as concurrent substance use, underlying psychiatric conditions, or socioeconomic factors), it is difficult to translate this organizational development into actionable clinical guidance. Practically speaking, healthcare providers should continue to maintain a high index of suspicion for cannabis use during [adolescent health](https://cedclinic.com/adolescent-cannabis-use-sexual-behavior-study/) screening, counsel patients about developmental risks based on existing evidence, and stay informed as research emerges from institutions like PHI that investigate these health effects. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-related-research/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Public+Health+Institute+Names+Ken+Shapiro+Chief+Development+and+Strategic+Initiatives+Officer+%40drcaplan&url=https%3A%2F%2Fwww.phi.org%2Fpress%2Fpublic-health-institute-names-ken-shapiro-chief-development-and-strategic-initiatives-officer%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.phi.org%2Fpress%2Fpublic-health-institute-names-ken-shapiro-chief-development-and-strategic-initiatives-officer%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Public+Health+Institute+Names+Ken+Shapiro+Chief+Development+and+Strategic+Initiatives+Officer+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww.phi.org%2Fpress%2Fpublic-health-institute-names-ken-shapiro-chief-development-and-strategic-initiatives-officer%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - [CED Digest: 436 Items — March 14, 2026](https://cedclinic.com/cannabis-compounds-fatty-liver-disease-2026/) - [CED Digest: 405 Items — March 12, 2026](https://cedclinic.com/alabama-medical-cannabis-sales-2026-spring-launch/) - [CED Digest: 392 Items — March 11, 2026](https://cedclinic.com/cannabis-compounds-fatty-liver-disease-2026/) 📰 Source: [https://www.phi.org/press/public-health-institute-names-ken-shapiro-chief-development-and-strategic-initiatives-officer/](https://www.phi.org/press/public-health-institute-names-ken-shapiro-chief-development-and-strategic-initiatives-officer/) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Adolescent Cannabis Use & Mental Health Risk: Clinical Evidence](https://cedclinic.com/adolescent-cannabis-psychotic-disorder-risk/) Review clinical evidence on how adolescent cannabis use impacts mental health and neurodevelopment. [Read Clinical Evidence](https://cedclinic.com/adolescent-cannabis-psychotic-disorder-risk/) [It may be legal for adults, but cannabis use a danger to young brains](https://cedclinic.com/it-may-be-legal-for-adults-but-cannabis-use-a-danger-to-young-brains/) Explore the risks of cannabis use on [adolescent brain development](https://cedclinic.com/adolescent-cb1-receptor-antagonism-social-behavior/) despite adult legalization. [Learn More](https://cedclinic.com/it-may-be-legal-for-adults-but-cannabis-use-a-danger-to-young-brains/) [New research highlights growing concerns around cannabis use among young adults … – Instagram](https://cedclinic.com/cannabis-use-disorder-young-adults-concerns/) Stay updated on emerging research highlighting concerns about cannabis use trends in young populations. [Explore Research](https://cedclinic.com/cannabis-use-disorder-young-adults-concerns/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).